Pipette tips can be seen sitting at a workstation in the lab at Sorrento Therapeutics in San Diego, California on May 22, 2020. - Last Friday researchers announced that the antibody,ST1-1499, it had been developing proved to be effective in blocking the COVID-19 virus in laboratory experiments. Sorrento Therapeutics is a biopharmaceutical company that researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic, and infectious diseases. (Photo by ARIANA DREHSLER / AFP) (Photo by ARIANA DREHSLER/AFP via Getty Images)
Leave a Reply